Adipotide kidney toxicity risk, anyone who tried it get bloodwork done?

Posted by greg_codes in Safety & Side Effects - 5 points, 4 comments.

Been looking into adipotide for targeted fat loss and ngl the mechanism is pretty interesting on paper. Cuts blood supply to white adipose tissue, fat cells get resorbed, no appetite suppression needed. Sounds sweet as right?

Yeah nah. The kidney toxicity is what bugs me. It's dose-dependent in the animal data and that's not something i'd want to mess around with blind. Kidneys don't exactly give you a heads up before things go sideways.

I haven't run it myself. Keen to hear from anyone who has. Did you get creatinine and eGFR checked before and after? Any changes in kidney markers? Dehydration seems to be a thing too based on what's out there, so hydration status would matter a lot for interpreting results.

Also wondering if anyone tracked injection site reactions? The profile mentions those and i'd want to know how bad we're talking. Like mild irritation or proper welt-type stuff?

For me the risk-reward feels off compared to glp-1 stuff where at least there's some human safety data behind it. But i'm curious if anyone here has real numbers to share. Actual bloodwork would be way more useful than "felt fine" anecdotes.

Comments

• labrat_vik: Haven't touched adipotide myself and honestly don't know anyone personally who has, which kinda tells you something right there. The kidney mechanism is the dealbreaker for me, it's not like a transient enzyme elevation you can walk off, the preclinical renal lesions were structural and once you're down that road you don't really get a do-over with nephrons. Creatinine and eGFR are blunt instruments too, they lag behind actual damage, so someone could post clean labs and still have meaningful i
• greg_codes: Ngl I’ve also stayed clear of adipotide. The structural kidney hit in animals is scary, and creatinine/eGFR lag. Cystatin C or even urine NGAL would give earlier warning if anyone ever dared to try.
• fasted_scientist: Ngl, the structural kidney hit is what stops me too – creatinine and eGFR can look fine while damage is already brewing. Cystatin C would be a step up, but even that’s not a guarantee without biopsy data. Has anyone actually ran adipotide and checked cystatin C or other early markers?
• greg_codes: Ngl, i’ve thought about adding cystatin c to the panel if i ever gave it a go, but the biopsy gap still feels too big for me. I’ve also glanced at ngal and kim‑1 as earlier hints, though nothing’s concrete without tissue proof. Yeah nah, i’ll stick to the data we have for now.

Community discussion - research and educational context only. Not medical advice.